• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国18至44岁女性乳腺癌对健康状态效用的影响

Health State Utility Impact of Breast Cancer in U.S. Women Aged 18-44 Years.

作者信息

Brown Derek S, Trogdon Justin G, Ekwueme Donatus U, Chamiec-Case Linda, Guy Gery P, Tangka Florence K, Li Chunyu, Trivers Katrina F, Rodriguez Juan L

机构信息

Brown School, Washington University in St. Louis, St. Louis, Missouri.

Department of Health Policy and Management, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.

出版信息

Am J Prev Med. 2016 Feb;50(2):255-61. doi: 10.1016/j.amepre.2015.07.020.

DOI:10.1016/j.amepre.2015.07.020
PMID:26775904
Abstract

INTRODUCTION

Breast cancer affects women's health-related quality of life negatively, but little is known about how breast cancer affects this in younger women aged 18-44 years. This study measures preference-based health state utility (HSU) values, a scaled index of health-related quality of life for economic evaluation, for younger women with breast cancer and compares these values with same-age women with other cancers and older women (aged ≥45 years) with breast cancer.

METHODS

Data from the 2009 and 2010 Behavioral Risk Factor Surveillance System were analyzed in 2014. The sample included 218,852 women; 7,433 and 18,577 had histories of breast and other cancers. HSU values were estimated using Healthy Days survey questions and a published mapping algorithm. Linear regression models for HSU were estimated by age group (18-44 and ≥45 years).

RESULTS

The adjusted breast cancer HSU impact was four times larger for younger women than for older women (-0.097 vs -0.024, p<0.001). For younger women, the effect of breast cancer on HSU was 70% larger than that of other cancers (-0.097 vs -0.057, p=0.024).

CONCLUSIONS

Younger breast cancer survivors reported lower HSU values than older survivors, highlighting the impact of breast cancer on the physical and mental health of younger women. The estimates may be used to evaluate quality-adjusted life-years or expectancy for prevention or treatment of breast cancer. This study also indicates that separate quality of life adjustments for women by age group are important for economic analysis of public health breast cancer interventions.

摘要

引言

乳腺癌会对女性与健康相关的生活质量产生负面影响,但对于18至44岁的年轻女性,乳腺癌如何影响她们的生活质量却鲜为人知。本研究测量了基于偏好的健康状态效用(HSU)值,这是一种用于经济评估的与健康相关生活质量的量化指标,研究对象为患有乳腺癌的年轻女性,并将这些值与患有其他癌症的同龄女性以及患有乳腺癌的老年女性(年龄≥45岁)进行比较。

方法

2014年对2009年和2010年行为风险因素监测系统的数据进行了分析。样本包括218,852名女性;其中7,433名和18,577名有乳腺癌和其他癌症病史。使用“健康天数”调查问题和一种已发表的映射算法来估计HSU值。按年龄组(18 - 44岁和≥45岁)估计HSU的线性回归模型。

结果

调整后的乳腺癌对HSU的影响在年轻女性中比老年女性大四倍(-0.097对-0.024,p<0.001)。对于年轻女性,乳腺癌对HSU的影响比其他癌症大70%(-0.097对-0.057,p = 0.024)。

结论

年轻的乳腺癌幸存者报告的HSU值低于年长的幸存者,这突出了乳腺癌对年轻女性身心健康的影响。这些估计值可用于评估预防或治疗乳腺癌的质量调整生命年或预期寿命。本研究还表明,按年龄组对女性进行单独的生活质量调整对于公共卫生乳腺癌干预措施的经济分析很重要。

相似文献

1
Health State Utility Impact of Breast Cancer in U.S. Women Aged 18-44 Years.美国18至44岁女性乳腺癌对健康状态效用的影响
Am J Prev Med. 2016 Feb;50(2):255-61. doi: 10.1016/j.amepre.2015.07.020.
2
Breast Cancer in Young Women: Health State Utility Impacts by Race/Ethnicity.年轻女性乳腺癌:种族/族裔对健康状态效用的影响
Am J Prev Med. 2016 Feb;50(2):262-9. doi: 10.1016/j.amepre.2015.09.026.
3
Productivity Costs Associated With Breast Cancer Among Survivors Aged 18-44 Years.18至44岁乳腺癌幸存者的生产力成本
Am J Prev Med. 2016 Feb;50(2):286-94. doi: 10.1016/j.amepre.2015.10.006.
4
Medical Care Costs of Breast Cancer in Privately Insured Women Aged 18-44 Years.18至44岁参加私人保险女性的乳腺癌医疗费用
Am J Prev Med. 2016 Feb;50(2):270-7. doi: 10.1016/j.amepre.2015.08.035.
5
Treatment Costs of Breast Cancer Among Younger Women Aged 19-44 Years Enrolled in Medicaid.参加医疗补助计划的19至44岁年轻女性乳腺癌的治疗费用
Am J Prev Med. 2016 Feb;50(2):278-85. doi: 10.1016/j.amepre.2015.10.017.
6
The Economics of Breast Cancer in Younger Women in the U.S.: The Present and Future.美国年轻女性乳腺癌的经济学:现状与未来。
Am J Prev Med. 2016 Feb;50(2):249-54. doi: 10.1016/j.amepre.2015.11.011.
7
Physical and mental health status and health behaviors in male breast cancer survivors: a national, population-based, case-control study.男性乳腺癌幸存者的身心健康状况和健康行为:一项全国性、基于人群的病例对照研究。
Psychooncology. 2012 Sep;21(9):927-34. doi: 10.1002/pon.2001. Epub 2011 Jun 21.
8
Symptom experience and quality of life of women following breast cancer treatment.乳腺癌治疗后女性的症状体验与生活质量
J Womens Health (Larchmt). 2007 Nov;16(9):1348-61. doi: 10.1089/jwh.2006.0255.
9
Constructs of burden of illness in older patients with breast cancer: a comparison of measurement methods.老年乳腺癌患者疾病负担的构成:测量方法比较
Health Serv Res. 2001 Dec;36(6 Pt 1):1085-107.
10
Sexual Minority Women's Health Behaviors and Outcomes After Breast Cancer.性少数女性乳腺癌患者的健康行为和结局。
LGBT Health. 2015 Sep;2(3):221-7. doi: 10.1089/lgbt.2014.0105. Epub 2015 Jun 2.

引用本文的文献

1
Impact of a Breast Cancer Diagnosis on Finances and Marital Status in Young Women.乳腺癌诊断对年轻女性财务状况和婚姻状况的影响。
BMC Womens Health. 2025 Feb 25;25(1):86. doi: 10.1186/s12905-025-03607-4.
2
A Systematic Literature Review of Health Utility Values in Breast Cancer.乳腺癌健康效用值的系统文献回顾
Med Decis Making. 2022 Jul;42(5):704-719. doi: 10.1177/0272989X211065471. Epub 2022 Jan 18.
3
Changes in Health State Utility Values in Japanese Patients with End-Stage Breast Cancer.日本晚期乳腺癌患者健康状态效用值的变化
Curr Oncol. 2021 Oct 18;28(5):4203-4212. doi: 10.3390/curroncol28050356.
4
A Meta-Regression Analysis of Utility Weights for Breast Cancer: The Power of Patients' Experience.乳腺癌效用权重的Meta回归分析:患者体验的影响力
Int J Environ Res Public Health. 2020 Dec 15;17(24):9412. doi: 10.3390/ijerph17249412.
5
Productivity costs associated with metastatic breast cancer in younger, midlife, and older women.转移性乳腺癌与年轻、中年和老年女性相关的生产力成本。
Cancer. 2020 Sep 15;126(18):4118-4125. doi: 10.1002/cncr.33077. Epub 2020 Jul 10.
6
Cost Effectiveness of Cladribine Tablets for the Treatment of Relapsing-Remitting Multiple Sclerosis in The Netherlands.克拉屈滨片治疗荷兰复发性缓解型多发性硬化症的成本效果分析。
Appl Health Econ Health Policy. 2019 Dec;17(6):857-873. doi: 10.1007/s40258-019-00500-8.
7
A Practical Guide to Conducting a Systematic Review and Meta-analysis of Health State Utility Values.健康状态效用值的系统评价和荟萃分析实用指南
Pharmacoeconomics. 2018 Sep;36(9):1043-1061. doi: 10.1007/s40273-018-0670-1.
8
Medical costs of treating breast cancer among younger Medicaid beneficiaries by stage at diagnosis.诊断时分期不同的年轻医疗补助受益患者乳腺癌的治疗费用。
Breast Cancer Res Treat. 2017 Nov;166(1):207-215. doi: 10.1007/s10549-017-4386-2. Epub 2017 Jul 12.
9
Racial/ethnicity disparities in invasive breast cancer among younger and older women: An analysis using multiple measures of population health.年轻女性和老年女性浸润性乳腺癌的种族/族裔差异:一项使用多种人群健康指标的分析
Cancer Epidemiol. 2016 Dec;45:112-118. doi: 10.1016/j.canep.2016.10.013. Epub 2016 Oct 25.
10
The Economics of Breast Cancer in Younger Women in the U.S.: The Present and Future.美国年轻女性乳腺癌的经济学:现状与未来。
Am J Prev Med. 2016 Feb;50(2):249-54. doi: 10.1016/j.amepre.2015.11.011.